FDA F*st Tr*cks “S*lf-Amplifying mRN* V*ccine C*ndidate” For B*rd Flu

The U.S. Food and Drug Administration (FDA) granted fast track designation for a “self-amplifying mRNA vaccine candidate” against bird flu.

Arcturus Therapeutics Holdings Inc., a commercial messenger RNA medicine company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that the